Trial intelligence / Profile preview

Naproxen for Bleeding in New Copper IUD Users

NCT02519231Phase 4Completed

Sponsor
University of Washington
Start
Feb 2016
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of naproxen in Menorrhagia, dysmenorrhea, sponsored by University of Washington. Started Feb 2016; status: completed.

02

Drugs

naproxen
03

Conditions

Menorrhagiadysmenorrhea

Beyond the preview

Go deeper on NCT02519231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02519231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call